Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free MNPR Stock Alerts

Monopar Therapeutics (MNPR) Short Interest Ratio & Short Volume

Monopar Therapeutics logo
$111.89 -2.05 (-1.80%)
As of 08/28/2026 04:00 PM Eastern
Compare

Monopar Therapeutics Short Interest Overview

As of August 14, 2026, Monopar Therapeutics (MNPR) had a short interest of 887,188 shares sold short, representing 14.64% of the public float. This marks a -16.70% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.5, meaning it would take 3.5 days of the average trading volume of 236,969 shares to cover all short positions.

Current Short Interest
887,188 shares
Previous Short Interest
1,065,108 shares
Change Vs. Previous Month
-16.70%
Dollar Volume Sold Short
$100.29 million
Short Interest Ratio
3.5 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
6,710,000 shares
Short Percent of Float
14.64%
Today's Trading Volume
221,544 shares
Average Trading Volume
236,969 shares
Today's Volume Vs. Average
93%
Short Selling Monopar Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Monopar Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MNPR Short Interest Over Time

MNPR Days to Cover Over Time

MNPR Percentage of Float Shorted Over Time

Monopar Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/2026887,188 shares $100.29 million -16.7%14.6%3.48 $113.04
7/31/20261,065,108 shares $115.40 million -21.7%17.6%3.4 $108.35
7/15/20261,360,286 shares $147.85 million -10.5%22.5%5.94 $108.69
6/30/20261,519,701 shares $140.71 million -2.5%25.1%8.61 $92.59
6/15/20261,558,148 shares $95.78 million -1.3%25.8%12.54 $61.47
5/29/20261,579,320 shares $102.72 million +0.6%29.7%8.53 $65.04
5/15/20261,569,220 shares $93.01 million -6.1%29.5%8.05 $59.27
4/30/20261,670,599 shares $87.12 million -3.1%31.4%10.6 $52.15
4/15/20261,723,274 shares $99.79 million +2.3%28.5%9.34 $57.91
3/31/20261,684,127 shares $92.27 million +1.9%27.8%7.98 $54.79
3/13/20261,653,442 shares $99.80 million +4.0%31.1%10.45 $60.36
2/27/20261,590,237 shares $87.16 million +5.6%29.9%10.83 $54.81
2/13/20261,506,521 shares $83.55 million +11.2%24.9%5.11 $55.46
1/30/20261,355,318 shares $81.83 million +5.9%25.5%4.26 $60.38
1/15/20261,279,274 shares $88.36 million +21.1%24.1%4.07 $69.07
12/31/20251,056,017 shares $68.96 million +28.3%19.9%3.11 $65.30
12/15/2025822,858 shares $61.81 million +62.2%15.5%4.55 $75.12
11/28/2025507,439 shares $43.13 million +36.7%9.6%4.04 $85.00
11/14/2025371,120 shares $28.95 million +44.5%7.0%1.99 $78.00
10/31/2025256,778 shares $22.12 million +58.6%5.2%2.58 $86.16
10/15/2025161,900 shares $14.64 million +9.5%3.9%2.9 $90.42
9/30/2025147,900 shares $12.08 million +0.7%3.5%3 $81.67
9/15/2025146,900 shares $8.00 million +7.7%3.7%2.9 $54.49
8/31/2025136,400 shares $4.66 million -2.8%3.5%3.3 $34.15
8/15/2025140,300 shares $5.01 million +3.6%3.6%3.4 $35.71
7/31/2025135,400 shares $5.58 million -0.8%3.4%3.6 $41.18
7/15/2025136,500 shares $5.43 million +5.1%3.5%3.7 $39.76
6/30/2025129,900 shares $4.65 million +415.5%3.3%4 $35.78
6/15/202525,200 shares $844.70 thousand -25.9%0.6%1.1 $33.52
5/31/202534,000 shares $1.09 million -10.5%0.9%1.4 $32.07
5/15/202538,000 shares $1.50 million -13.8%1.0%1.5 $39.55
4/30/202544,100 shares $1.84 million -5.8%1.1%1.3 $41.82
4/15/202546,800 shares $1.80 million -9.7%1.2%1.1 $38.36
3/31/202551,800 shares $1.89 million +2.2%1.3%1 $36.41
3/15/202550,700 shares $1.51 million -1.2%1.3%0.9 $29.75
2/28/202551,300 shares $1.80 million +57.9%1.3%0.8 $35.11
2/15/202532,500 shares $1.40 million +6.2%0.8%0.4 $43.10
1/31/202530,600 shares $1.34 million -13.3%0.7%0.4 $43.94
1/15/202535,300 shares $949.92 thousand -3.3%0.8%0.1 $26.91
12/31/202436,500 shares $803 thousand +41.5%0.8%0.1 $22.00
Why the Treasury still prices gold at 42 dollars an ounce (Ad)

The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades near 4,500 dollars today, a 113-to-1 gap between book value and market reality. Treasury Secretary Scott Bessent has said he wants to monetize the asset side of the balance sheet. A revaluation could add more than 1 trillion dollars to the government's books overnight. Certain gold miners still trade as if gold were under 2,000 dollars, even as prices near record highs.tc pixel

See the four gold miners positioned ahead of a potential Treasury revaluation.
12/15/202425,800 shares $654.80 thousand +17.3%0.6%0 $25.38
11/30/202422,000 shares $495.66 thousand -18.2%0.7%0 $22.53
11/15/202426,900 shares $486.62 thousand -62.6%0.9%0 $18.09
10/31/202472,000 shares $1.05 million +44.3%3.6%0.1 $14.57
10/15/202449,900 shares $256.99 thousand -55.6%2.8%0 $5.15
9/30/2024112,400 shares $757.58 thousand -82.8%6.4%0.1 $6.74
9/15/2024652,500 shares $2.52 million +603.1%36.9%0.9 $3.86
8/31/202492,800 shares $221.79 thousand +211.4%5.2%1.6 $2.39
8/15/202429,800 shares $70.63 thousand -66.8%1.7%0.5 $2.37
7/31/202489,800 shares $305.77 thousand +53.2%1.0%0.8 $3.41
7/15/202458,600 shares $41.61 thousand -29.2%0.7%0.5 $0.71
6/30/202482,800 shares $60.45 thousand -4.5%1.0%0.6 $0.73
6/15/202486,700 shares $81.50 thousand +38.5%1.0%0.6 $0.94
5/31/202462,600 shares $38.25 thousand -21.6%0.7%0.4 $0.61
5/15/202479,800 shares $47.73 thousand -13.5%0.9%0.1 $0.60
4/30/202492,300 shares $60.93 thousand -38.5%1.2%0 $0.66
4/15/2024150,000 shares $114 thousand -12.0%2.0%0 $0.76
3/31/2024170,500 shares $116.11 thousand -25.7%2.3%0 $0.68
3/15/2024229,600 shares $149.47 thousand -73.0%3.6%0 $0.65
2/29/2024848,800 shares $704.50 thousand +1,251.6%13.3%0.2 $0.83
2/15/202462,800 shares $21.36 thousand +192.1%1.0%0 $0.34
1/31/202421,500 shares $7.21 thousand -76.6%0.3%0.1 $0.34
1/15/202491,900 shares $39.94 thousand -12.8%1.4%0.1 $0.43
12/31/2023105,400 shares $35.86 thousand +51.4%1.7%0.1 $0.34
12/15/202369,600 shares $25.66 thousand -59.0%1.1%0.1 $0.37
11/30/2023169,900 shares $50.97 thousand -9.5%2.8%0.2 $0.30
11/15/2023187,800 shares $62.01 thousand +277.9%3.1%0.2 $0.33
10/31/202349,700 shares $22.32 thousand +7.8%0.9%0.1 $0.45
10/15/202346,100 shares $21.26 thousand +27.0%0.8%0.3 $0.46
9/30/202336,300 shares $22.50 thousand -43.9%0.6%0.1 $0.62
9/15/202364,700 shares $39.17 thousand -33.0%1.1%0.3 $0.61
8/31/202396,600 shares $62.40 thousand -65.8%1.9%0.4 $0.65
8/15/2023282,600 shares $192.17 thousand +361.0%5.5%0.6 $0.68
7/31/202361,300 shares $45.42 thousand +53.3%1.3%0.1 $0.74
7/15/202340,000 shares $40 thousand -65.4%0.8%0.1 $1.00
6/30/2023115,600 shares $98.84 thousand -58.6%2.4%0.4 $0.86
6/15/2023279,100 shares $235.92 thousand +231.1%5.7%1 $0.85
5/31/202384,300 shares $82.45 thousand +6.6%1.7%0.3 $0.98
5/15/202379,100 shares $68.03 thousand +4.9%1.4%2.6 $0.86
4/30/202375,400 shares $84.83 thousand +20.8%1.4%2.3 $1.13
4/15/202362,400 shares $78.76 thousand -32.5%1.1%1.7 $1.26
3/31/202392,400 shares $128.45 thousand +41.1%1.7%2.5 $1.39
3/15/202365,500 shares $172.27 thousand +65.0%1.2%2.9 $2.63
2/28/202339,700 shares $124.26 thousand +25.6%0.8%1.4 $3.13
2/15/202331,600 shares $116.92 thousand -36.2%0.6%1.2 $3.70
1/31/202349,500 shares $177.21 thousand +269.4%0.9%1.3 $3.58
1/15/202313,400 shares $36.60 thousand +78.7%0.3%0.4 $2.73
12/30/20227,500 shares $17.78 thousand -72.7%0.1%0.2 $2.37
12/15/202227,500 shares $72.88 thousand -32.4%0.5%0.9 $2.65
11/30/202240,700 shares $104.60 thousand +26.8%0.8%1.6 $2.57
MILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)

James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.tc pixel

Watch James Altucher's free masterclass before September 25
11/15/202232,100 shares $90.20 thousand +98.2%0.6%1.3 $2.81
10/31/202216,200 shares $39.85 thousand +47.3%0.3%0.7 $2.46
10/15/202211,000 shares $19.80 thousand -37.5%0.2%1.1 $1.80
9/30/202217,600 shares $26.75 thousand +50.4%0.3%1.7 $1.52
9/15/202211,700 shares $19.07 thousand +62.5%0.2%1.1 $1.63
8/31/20227,200 shares $12.96 thousand +166.7%0.1%0.7 $1.80
8/15/20222,700 shares $5.00 thousand -70.0%0.1%0.3 $1.85
7/31/20229,000 shares $17.64 thousand +38.5%0.2%0.9 $1.96
7/15/20226,500 shares $14.63 thousand -12.2%0.1%0.7 $2.25
6/30/20227,400 shares $17.02 thousand +13.9%0.2%0.8 $2.30
6/15/20226,500 shares $13.33 thousand -40.9%0.1%0.8 $2.05
5/31/202211,000 shares $23.54 thousand +254.8%0.2%1.5 $2.14
5/15/20223,100 shares $6.26 thousand -18.4%0.1%0.4 $2.02
4/30/20223,800 shares $8.66 thousand +31.0%0.1%0.6 $2.28
4/15/20222,900 shares $7.19 thousand -55.4%0.1%0.5 $2.48
3/31/20226,500 shares $16.58 thousand +140.7%0.1%0.6 $2.55
3/15/20222,700 shares $7.32 thousand -29.0%0.1%0.2 $2.71
2/28/20223,800 shares $11.74 thousand -46.5%0.1%0.2 $3.09
2/15/20227,100 shares $20.80 thousand -59.9%0.1%0.4 $2.93
1/31/202217,700 shares $52.22 thousand -10.2%0.4%0.9 $2.95
1/15/202219,700 shares $58.31 thousand -30.4%0.4%0.7 $2.96
12/31/202128,300 shares $90.84 thousand -25.7%0.6%1 $3.21
12/15/202138,100 shares $146.69 thousand -24.1%0.8%1.5 $3.85
11/30/202150,200 shares $220.88 thousand -37.2%1.0%0.7 $4.40
11/15/202179,900 shares $388.31 thousand -7.5%1.6%1.1 $4.86
10/29/202186,400 shares $414.72 thousand +11.2%1.7%1.2 $4.80
10/15/202177,700 shares $381.51 thousand -3.5%1.5%1 $4.91
9/30/202180,500 shares $392.04 thousand -17.2%1.6%1.1 $4.87
9/15/202197,200 shares $480.17 thousand +85.5%1.9%1.3 $4.94
8/31/202152,400 shares $270.91 thousand -16.0%1.0%0.7 $5.17

MNPR Short Interest - Frequently Asked Questions

Short interest is the volume of Monopar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 14th, investors have sold 887,188 shares of MNPR short. 14.64% of Monopar Therapeutics' shares are currently sold short. Learn More on Monopar Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNPR shares currently have a short interest ratio of 3.5. Learn More on Monopar Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.64% of Monopar Therapeutics' floating shares are currently sold short.

Monopar Therapeutics saw a decrease in short interest in August. As of August 14th, there was short interest totaling 887,188 shares, a decrease of 16.7% from the previous total of 1,065,108 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

14.64% of Monopar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Monopar Therapeutics: Alumis Inc. (6.82%), Beam Therapeutics Inc. (24.53%), Zai Lab Limited Unsponsored ADR (6.90%), SELLAS Life Sciences Group, Inc. (28.28%), Nurix Therapeutics, Inc. (18.57%), Viridian Therapeutics, Inc. (17.21%), Precigen, Inc. (20.22%), Ultragenyx Pharmaceutical Inc. (17.00%), Nektar Therapeutics (18.53%), BioCryst Pharmaceuticals, Inc. (13.40%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling MNPR is an investing strategy that aims to generate trading profit from Monopar Therapeutics as its price is falling. MNPR shares are trading down $2.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Monopar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNPR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNPR, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MNPR:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:MNPR is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Leading AI Insider Issues Urgent Market Warning
A leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...
TradeSmith | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
Buy this stock today
Most tech companies skip dividends entirely. This one doesn't, paying shareholders like clockwork while flying...
Chaikin Analytics | Sponsoredtc pixel